Terms: = Lung cancer AND TLX1, P31314, 3195, ENSG00000107807, TCL3, HOX11 AND Treatment
4 results:
1. Effectivity and safety of PD-1/PD-L1 inhibitors for different level of PD-L1-positive, advanced NSCLC: A meta-analysis of 4939 patients from randomized controlled trials.
Shi Y; Duan J; Guan Q; Xue P; Zheng Y
Int Immunopharmacol; 2020 Jul; 84():106452. PubMed ID: 32339922
[TBL] [Abstract] [Full Text] [Related]
2. lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series.
Francia CM; Marvaso G; Piperno G; Gandini S; Ferrari A; Zerella MA; Arculeo S; Sibio D; Fodor C; Pepa M; Trivellato S; Rondi E; Vigorito S; Cattani F; Spaggiari L; De Marinis F; Orecchia R; Ciardo D; Jereczek-Fossa BA
Neoplasma; 2020 May; 67(3):684-691. PubMed ID: 32182088
[TBL] [Abstract] [Full Text] [Related]
3. Prostate cancer Brain Metastases: A Single-Institution Experience.
Bhambhvani HP; Greenberg DR; Srinivas S; Hayden Gephart M
World Neurosurg; 2020 Jun; 138():e445-e449. PubMed ID: 32147556
[TBL] [Abstract] [Full Text] [Related]
4. Age and the treatment of lung cancer.
Brown JS; Eraut D; Trask C; Davison AG
Thorax; 1996 Jun; 51(6):564-8. PubMed ID: 8693434
[TBL] [Abstract] [Full Text] [Related]
